A Study of STSA-1201 in Healthy Subjects

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This study is a Phase Ia, randomized, double-blind, placebo-controlled, single dose, dose escalation safety, tolerability, and pharmacokinetic study of STSA-1201 injection in healthy subjects. A total of 44 healthy subjects were enrolled in four dosage groups.
Epistemonikos ID: 1b3d214ca919acdb16b9b5cd2531d77e4f2f8a59
First added on: May 15, 2024